Mode
Text Size
Log in / Sign up
N/A N=25 Randomized Double-blind Treatment

A Comparison of Two Daily Disposable Contact Lenses.

Refractive Error · Myopia

Enrolled (actual)
25
Serious AEs
0.0%
Results posted
Mar 2011
Primary outcome: Primary: Proportion of Eyes Successfully Fit — 0.98; 0.96; 0.96; 0.96 proportion of participant eyes

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
etafilcon A (Device); narafilcon A (Device)
Age
Adult · 18+ yrs
Sex
All
Sponsor
Johnson & Johnson Vision Care, Inc.
Primary completion
Jul 2008

Outcome Measures

OutcomeResultp-value
PRIMARY
Proportion of Eyes Successfully Fit
0.98; 0.96; 0.96; 0.96
PRIMARY
Lens Fit Decentration
0.25; 0.22; 0.27; 0.27
PRIMARY
Lens Tightness on Cornea With Manual Digit Push Up
44.6; 46.9; 56.3; 58.1

Summary

This study seeks to evaluate the clinical fitting performance of a new daily disposable contact lens to an existing daily disposable contact lens.

Eligibility Criteria

Inclusion Criteria

  • They are of legal age (18 years) and capacity to volunteer.
  • They understand their rights as a research subject and are willing to sign a Statement of Informed Consent.
  • They are willing and able to follow the protocol.
  • They would be expected to attain at least 6/9 (20/30) in each eye with the study lenses.
  • They are able to wear contact lenses with a back vertex power of -1.00 to -6.00DS.
  • They have a maximum of 1.00D of refractive astigmatism (i.e. ≤ 1.00 DC).
  • They have successfully worn contact lenses within six months of starting the study.

Exclusion Criteria

  • They have an ocular disorder which would normally contra-indicate contact lens wear.
  • They have a systemic disorder which would normally contra-indicate contact lens wear.
  • They are using any topical medication such as eye drops or ointment.
  • They are aphakic.
  • They have had corneal refractive surgery.
  • They have any corneal distortion resulting from previous hard or rigid lens wear or has keratoconus.
  • They are pregnant or lactating.
  • They have grade 2 or greater of any of the following ocular surface signs: corneal oedema, corneal vascularisation, corneal staining, tarsal conjunctival changes or any other abnormality which would normally contraindicate contact lens wear.
  • They have any infectious disease (e.g. hepatitis) or any immunosuppressive disease (e.g. HIV).
  • They have diabetes.
  • They have taken part in any other clinical trial or research, within two weeks prior to starting this study.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00721500). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search